儿童期CT扫描后的癌症风险估计:法国CT队列研究的更新
该研究对2000至2011年间首次接受CT检查的儿童进行随访至2016年12月31日、死亡、首次癌症诊断或18岁生日中最早发生者,采用Cox模型估计累积器官剂量与性别相关的风险比。在无癌症易感因素的患者中,脑部平均累积剂量为27.7 mGy,红骨髓为10.3 mGy;每10 mGy的HR为中枢神经系统肿瘤1.05(95%CI:1.01-1.09)、白血病1.17(95%CI:1.09-1.26)、淋巴瘤0.96(95%CI:0.63-1.45)。研究显示无癌症易感因素患者的中枢神经系统肿瘤和白血病存在统计学显著的剂量-反应关系。
要点
- 无癌症易感因素患儿每10 mGy累积剂量的中枢神经系统肿瘤HR为1.05(95%CI:1.01-1.09)。
- 无癌症易感因素患儿每10 mGy累积剂量的白血病HR为1.17(95%CI:1.09-1.26)。
- 淋巴瘤每10 mGy的HR为0.96(95%CI:0.63-1.45),未达统计学显著。
核心结论
- 本研究显示,在无癌症易感因素的患者中,中枢神经系统肿瘤和白血病与CT累积器官剂量存在统计学显著的剂量-反应关系。
- 淋巴瘤每10 mGy的HR为0.96(95%CI:0.63-1.45),未达统计学显著。
- 纳入参与医院外进行的CT扫描或纳入期后进行的CT扫描未改变上述估计。
研究设计与样本
- 法国CT队列研究的更新分析,随访自首次CT日期(2000年至2011年间)至队列退出日期,即2016年12月31日、死亡日期、首次癌症诊断日期或18岁生日中最早者。
- 通过国家外部数据库收集癌症发病率、生命状态、癌症易感因素及额外CT扫描信息。
- 采用Cox模型估计累积器官剂量和性别相关的风险比(HR)。
诊断标准与关键数值
- 随访结束时脑部平均累积剂量为27.7 mGy,红骨髓平均累积剂量为10.3 mGy。
- 无癌症易感因素患者中,每10 mGy累积剂量的中枢神经系统肿瘤HR为1.05(95%CI:1.01-1.09)。
- 无癌症易感因素患者中,每10 mGy累积剂量的白血病HR为1.17(95%CI:1.09-1.26)。
- 无癌症易感因素患者中,每10 mGy累积剂量的淋巴瘤HR为0.96(95%CI:0.63-1.45)。
临床应用与阅片要点
- CT是法国人群诊断影像集体剂量的最重要贡献因素。
- 由于儿童辐射敏感性更高且预期寿命更长,儿童期CT暴露后的可能癌症风险受到关注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Increased risks of central nervous system (CNS) tumors and leukemia associated with computed tomography (CT) exposure during childhood have been reported in recent epidemiological studies. However, no evidence of increased risks was suggested in a previous analysis of the French CT cohort. This study benefits from an updated cohort with a longer follow-up and a larger sample size of patients.
METHODS: The patients were followed from the date of their first CT (between 2000 and 2011) until their date of cohort exit defined as the earliest among the following: 31 December 2016, date of death, date of first cancer diagnosis or date of their 18th birthday. Cancer incidence, vital status, cancer predisposing factors (PFs), and additional CT scans were collected via external national databases. Hazard ratios (HRs) associated to cumulative organ doses and sex were estimated from Cox models.
RESULTS: At the end of follow-up, mean cumulative doses were 27.7 and 10.3 mGy for the brain and the red bone marrow (RBM), respectively. In patients without PFs, an HR per 10 mGy of 1.05 (95% CI: 1.01-1.09) for CNS tumors, 1.17 (95% CI: 1.09-1.26) for leukemia, and 0.96 (95% CI: 0.63-1.45) for lymphoma was estimated. These estimates were not modified by the inclusion of CT scans performed outside the participating hospitals or after the inclusion period.
CONCLUSIONS: This study shows statistically significant dose-response relationships for CNS tumors and leukemia for patients without PFs.
KEY POINTS: • Computed tomography is the most important contributor to the collective dose for diagnostic imaging to the French population. • Concerns have been raised about possible cancer risks, particularly after exposure to CT in childhood, due to the greater radiation sensitivity of children and to their longer life expectancy. • Analysis of the updated French CT cohort shows statistically significant dose-response relationships for CNS tumors and leukemia.
引用
- Foucault, Ancelet, Dreuil, et al. Childhood cancer risks estimates following CT scans: an update of the French CT cohort study. Eur Radiol. 2022. PMID: 35230516. doi:10.1007/s00330-022-08602-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。